ATE227982T1 - Orale gelkapselformulierung von 1,2,4- benzotriazinoxiden - Google Patents

Orale gelkapselformulierung von 1,2,4- benzotriazinoxiden

Info

Publication number
ATE227982T1
ATE227982T1 AT96928255T AT96928255T ATE227982T1 AT E227982 T1 ATE227982 T1 AT E227982T1 AT 96928255 T AT96928255 T AT 96928255T AT 96928255 T AT96928255 T AT 96928255T AT E227982 T1 ATE227982 T1 AT E227982T1
Authority
AT
Austria
Prior art keywords
capsule formulation
gel capsule
oral gel
benzotriazine oxides
benzotriazine
Prior art date
Application number
AT96928255T
Other languages
English (en)
Inventor
Stephen Brown
Ross Blundell
Original Assignee
Sanofi Synthelabo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo Inc filed Critical Sanofi Synthelabo Inc
Application granted granted Critical
Publication of ATE227982T1 publication Critical patent/ATE227982T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96928255T 1995-09-12 1996-08-21 Orale gelkapselformulierung von 1,2,4- benzotriazinoxiden ATE227982T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/527,233 US5597582A (en) 1995-09-12 1995-09-12 Oral gel capsule formulation of 1,2,4-benzotriazine oxides
PCT/US1996/013517 WO1997009968A1 (en) 1995-09-12 1996-08-21 Oral gel capsule formulation of 1,2,4-benzotriazine oxides

Publications (1)

Publication Number Publication Date
ATE227982T1 true ATE227982T1 (de) 2002-12-15

Family

ID=24100665

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96928255T ATE227982T1 (de) 1995-09-12 1996-08-21 Orale gelkapselformulierung von 1,2,4- benzotriazinoxiden

Country Status (19)

Country Link
US (1) US5597582A (de)
EP (1) EP0868174B1 (de)
JP (1) JPH11513365A (de)
KR (1) KR100475388B1 (de)
CN (1) CN1080113C (de)
AT (1) ATE227982T1 (de)
AU (1) AU702550B2 (de)
CA (1) CA2231545C (de)
CZ (1) CZ289733B6 (de)
DE (1) DE69624935T2 (de)
DK (1) DK0868174T3 (de)
ES (1) ES2187668T3 (de)
HK (1) HK1016889A1 (de)
HU (1) HUP9802605A3 (de)
MX (1) MX9801930A (de)
NO (1) NO320019B1 (de)
NZ (1) NZ315964A (de)
PT (1) PT868174E (de)
WO (1) WO1997009968A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484612A (en) * 1993-09-22 1996-01-16 The Board Of Trustees Of The Leland Stanford Junior University Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin
US6365181B1 (en) 2000-04-20 2002-04-02 Gattefosse Corporation Thixatropic gelatin carrier composition
CA2456569A1 (en) * 2003-03-14 2004-09-14 Auckland Uniservices Limited Benzoazine mono-n-oxides and benzoazine 1,4 dioxides and compositions therefrom for the therapeutic use in cancer treatments
US8642079B2 (en) * 2004-02-23 2014-02-04 Hormos Medical Corporation Solid formulations of ospemifene
US8758821B2 (en) * 2004-05-04 2014-06-24 Hormos Medical Ltd. Oral formulations of ospemifene
SI2275098T1 (sl) * 2004-05-04 2012-12-31 Hormos Medical Ltd. Nove oralne formulacije ospemifena
CN104705772B (zh) * 2015-01-28 2016-09-14 汤臣倍健股份有限公司 一种改善软胶囊漏油的生产工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤
US5175287A (en) * 1986-09-25 1992-12-29 S R I International Process for preparing 1,2,4-benzotriazine oxides
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
US5484612A (en) * 1993-09-22 1996-01-16 The Board Of Trustees Of The Leland Stanford Junior University Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin
WO1996037192A1 (en) * 1995-05-26 1996-11-28 Vesifact Ag Pharmaceutical and cosmetic compositions containing sphingo- and glycolipids
US5637085A (en) * 1995-11-20 1997-06-10 Cardinale; Robert M. Method of cancer tumor treatment by slow release delivery of 1,2,4-benzotriazine oxides to tumor site

Also Published As

Publication number Publication date
CA2231545A1 (en) 1997-03-20
DE69624935T2 (de) 2003-03-27
MX9801930A (es) 1998-10-31
AU6780096A (en) 1997-04-01
CN1200669A (zh) 1998-12-02
DK0868174T3 (da) 2003-03-17
KR19990044573A (ko) 1999-06-25
NZ315964A (en) 1999-03-29
DE69624935D1 (de) 2003-01-02
WO1997009968A1 (en) 1997-03-20
NO320019B1 (no) 2005-10-10
EP0868174B1 (de) 2002-11-20
CZ289733B6 (cs) 2002-03-13
HK1016889A1 (en) 1999-11-12
KR100475388B1 (ko) 2005-08-05
EP0868174A4 (de) 1998-10-07
PT868174E (pt) 2003-04-30
HUP9802605A3 (en) 2000-02-28
JPH11513365A (ja) 1999-11-16
AU702550B2 (en) 1999-02-25
ES2187668T3 (es) 2003-06-16
NO981042L (no) 1998-03-10
CA2231545C (en) 2008-07-15
US5597582A (en) 1997-01-28
HUP9802605A2 (hu) 1999-04-28
CZ64498A3 (cs) 1998-08-12
EP0868174A1 (de) 1998-10-07
NO981042D0 (no) 1998-03-10
CN1080113C (zh) 2002-03-06

Similar Documents

Publication Publication Date Title
DE68905224T2 (de) Transendoskopische implantatkapsel.
NO167384C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-aralkylpiperidinmethanolderivater.
CA2310585A1 (en) Novel administration form comprising an acid-labile active compound
CA2109623A1 (en) Process for solubilizing difficultly soluble pharmaceutical actives
DE68911473D1 (de) Arzneimittelformulierungen.
NL195028B (nl) Cyclosporinebevattend farmaceutisch preparaat.
ZA9511034B (en) Soft gelatin pharmaceutical dosage form
DE69525019D1 (de) Cyclosporin enthaltende Weichkapselzusammensetzungen
DE69711267D1 (de) Cyclosporin enthaltende Weichkapselpräparate
FI941447A (fi) Suun kautta annettavat, kapseleina olevat ubidekarenonivalmisteet
ATE227982T1 (de) Orale gelkapselformulierung von 1,2,4- benzotriazinoxiden
DE3776620D1 (de) 3-propenylcephemderivate, ihre herstellung, zwischenverbindungen, pharmazeutische praeparate und anwendung.
NO980296D0 (no) Forbedrede terapeutiske midler
DE3888739D1 (de) Submunitions-Wirkteil, sowie Flechettes-Gefechtskopf und Flechettes dafür.
BR9506389B1 (pt) composto de silìcio, e, composição dietética, cosmética e terapêutica.
NO873108D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-benzodiazepiner.
DE68906245T2 (de) Therapeutisches Mittel gegen Aids.
NO905327L (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbamoylderivater.
DE9414607U1 (de) Parfümkapsel
FI903885A0 (fi) Ny oral farmaceutisk doseringsform som foerbaettrar biotillgaengligheten.
DE3669497D1 (de) Cycloalkan-1-ol derivate und duftstoff-zusammensetzungen, die diese enthalten.
SU982197A1 (ru) Резервированный счетчик импульсов
MA21243A1 (fr) Shampooing doux .
ITTO950545A0 (it) Vaccino/composizioni terapautica di helycobacter pylori, loro prepara-zione ed impiego.
DE58902121D1 (de) Weichgelatinekapsel.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0868174

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee